< Back to latest news & events

Event

IP in Healthcare Conference 2020

March 2020

Event date: 3rd March 2020

March 2020 in London and Manchester. HGF’s sixth annual Healthcare Conference reviews the latest intellectual property issues in the pharmaceuticals, life sciences and medical devices sectors.

Update

It is with great regret that we have taken the decision to cancel the HGF IP in Healthcare conference in London on Thursday 12th March. This is a precautionary measure by the firm based on current situation surrounding the Coronavirus in the UK and Europe.

We would like to take this opportunity to thank you for reserving your place and we look forward to welcoming you again in 2021.

Dates

The Conference will take place on the following dates:

  • Tuesday 3rd March in Alderley Park, Manchester
  • Thursday 12th March in Barber-Surgeons Hall, London *Cancelled*
About HGF Healthcare team

HGF’s Healthcare team provides professional expertise and commercially focused advice to business leaders and decision makers in the healthcare fields of life sciences, pharmaceuticals and medical devices. HGF has in-depth knowledge of the sector, and the experience to provide you with high quality and commercially focused advice in relation to the protection of your IP rights. The team offers the full range of IP services including:

  • IP strategy and advice;
  • Patent and trade mark procurement;
  • IP portfolio management;
  • Freedom-to-operate advice and opinions;
  • IP due diligence assessments and opinions;
  • Supplementary protection certificates and data exclusivity advice;
  • IP licences and agreements;
  • IP disputes management and litigation

For more information on the team please click here.

Please join our Healthcare+IP LinkedIn group which discusses stories and legal developments in the intellectual property field which impacts the healthcare sector.

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24.

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

Agritech Thymes: Agritech 2030: Forecasting the Technologies Poised to Transform Farming

Whilst yet to recover to the levels of 2011-2021, where capital invested in agritech increased 20-fold, investor funding in agritech is starting to pick up, and 2025 is set to …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article